Atlas Trials

Safety Study to Assess Whether Proinsulin Peptide Injections Can Slow or Stop the Body Damaging Its Own Insulin-making Cells in the Pancreas in Patients Newly Diagnosed With Type 1 Diabetes

Clinical trial NCT01536431 · COMPLETED

Trial details

NCT number
NCT01536431
Sponsor
Cardiff University
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Type 1 Diabetes
Start date
2012-01-01
Primary completion
2015-02-01
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.